Contract Manufacturing
Small-to-medium sized pharmaceutical and biotech companies are positioned to bring 50 percent of new drug molecules to market in the next decade. With escalating R&D costs and the long path to new medicine, these companies are forced to view outsourcing or contract services as an important part of their manufacturing strategy.
Biocon leverages its India cost-base together with its extensive expertise and technology platforms to offer competitive, high quality, custom manufacturing services to a global clientele. Our full set of manufacturing capabilities, include mammalian cell culture fermentation, microbial cell culture fermentation, synthetic chemistry, formulation development for solid dosage (tablets and capsules) for immediate and modified release, injectables (vials, cartridges, lyophilized and pre filled syringes) and a fill finish facility. Inspected by US FDA on more then one occasion, our facilities are internationally benchmarked making us partners of choice for companies seeking innovative solutions for their medication delivery needs.
|